PROMINENT (Completed) Pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in diabetic patients Medicine pemafibrate Population Diabetes mellitus Phase III Starting year 2016 More information Clinicaltrials.gov Publicaties PROMINENT
